Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

526
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
526
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

877
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
877
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

939
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
939
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

287
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
287
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

212
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
212
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

289
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
289

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New percentiles of gamma-glutamyl transferase serum levels in infants and the role of breastfeeding.

BMC pediatrics·2026
Same author

The Italian biliary atresia registry: Insights and lessons from the retrospective analysis of a 10-year period cohort.

Journal of pediatric gastroenterology and nutrition·2026
Same author

Cenobamate use in super-refractory status epilepticus: A report of three cases.

Epileptic disorders : international epilepsy journal with videotape·2026
Same author

Clinical Characteristics and Treatment Management of Seronegative Myasthenia Gravis: A Systematic Review of the Literature.

Muscle & nerve·2026
Same author

HEPATITIS A RESURGENCE: TIME TO RECONSIDER ROUTINE PAEDIATRIC IMMUNISATION.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Myasthenia gravis misdiagnosis in the era of innovative therapies: Uncovering pitfalls and patterns.

Journal of neuroimmunology·2026

Related Experiment Video

Updated: Jan 22, 2026

Generation of Induced Pluripotent Stem Cells from Turner Syndrome 45XO Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome
09:39

Generation of Induced Pluripotent Stem Cells from Turner Syndrome 45XO Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome

Published on: December 4, 2021

3.5K

Paraneoplastic neurological syndromes.

Raffaele Iorio1, Gregorio Spagni2, Gianvito Masi2

  • 1Institute of Neurology, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Roma, Italy; Università Cattolica del Sacro Cuore, Roma, Italy.

Seminars in Diagnostic Pathology
|June 30, 2019
PubMed
Summary

Paraneoplastic neurological syndromes (PNS) involve immune responses against tumors, leading to nervous system damage. Discovering autoantibodies aids in diagnosing and treating these rare neurological disorders.

More Related Videos

Portable Thermographic Screening for Detection of Acute Wallenberg's Syndrome
05:12

Portable Thermographic Screening for Detection of Acute Wallenberg's Syndrome

Published on: September 19, 2019

7.0K
Recording Horizontal Saccade Performances Accurately in Neurological Patients Using Electro-oculogram
06:12

Recording Horizontal Saccade Performances Accurately in Neurological Patients Using Electro-oculogram

Published on: March 13, 2018

11.1K

Related Experiment Videos

Last Updated: Jan 22, 2026

Generation of Induced Pluripotent Stem Cells from Turner Syndrome 45XO Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome
09:39

Generation of Induced Pluripotent Stem Cells from Turner Syndrome 45XO Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome

Published on: December 4, 2021

3.5K
Portable Thermographic Screening for Detection of Acute Wallenberg's Syndrome
05:12

Portable Thermographic Screening for Detection of Acute Wallenberg's Syndrome

Published on: September 19, 2019

7.0K
Recording Horizontal Saccade Performances Accurately in Neurological Patients Using Electro-oculogram
06:12

Recording Horizontal Saccade Performances Accurately in Neurological Patients Using Electro-oculogram

Published on: March 13, 2018

11.1K

Area of Science:

  • Neuroimmunology
  • Oncology
  • Neurology

Background:

  • Paraneoplastic neurological syndromes (PNS) are diverse nervous system disorders linked to cancer.
  • They arise from immune responses targeting tumor-expressed neural antigens.
  • Neural-specific autoantibodies are key markers in PNS.

Purpose of the Study:

  • To review the advancements in understanding PNS.
  • To highlight the role of autoantibody discovery in PNS diagnosis and treatment.
  • To identify areas needing further research in PNS immunopathogenesis and treatment.

Main Methods:

  • Literature review of recent advancements in autoimmune neurology and PNS research.
  • Analysis of the impact of novel autoantibody discoveries.
  • Synthesis of current knowledge on PNS immunopathogenesis and therapeutic strategies.

Main Results:

  • Significant progress in identifying autoantibodies associated with PNS.
  • Improved diagnostic accuracy and earlier treatment initiation due to autoantibody findings.
  • Enhanced understanding of the immune mechanisms underlying PNS.

Conclusions:

  • Autoantibody characterization is crucial for PNS diagnosis, treatment, and prognosis.
  • Recent discoveries have improved patient outcomes, but further research is needed.
  • Optimizing patient-tailored treatment strategies for PNS remains an ongoing challenge.